Thread by @MondayNightIBD

🙌 @my_ueg X #MondayNightIBD 🙌◦◦◦◦◦◦◦◦◦◦◦◦🎯 Best of #UEGWeek ◦◦◦◦ CME🔗bit.ly/MNIBD-UEG2022 ◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦◦ Support by edu grants from @abbvie & BMS twitter.com/i/broadcasts/1…

2/#MondayNightIBD #UEGWeek
🆓#CME🔗bit.ly/3XgqsH8

📲Tweet your❓for Mon LIVE Q&A @ 2p ET/ 7p GMT/ 8p CEST

📍Where are you in your career?

3/ #MondayNightIBD X #UEGWeek 2022 Best in #IBD

✨Faculty @Iris_Dotan, @CharlieMuz, @MRegueiroMD, & @DCharabaty ✨

🤝 In collab w/ @my_ueg, @BonumCe

🆓#CME🔗bit.ly/3XgqsH8

📲Tweet you questions👇🏽to be answered LIVE by the experts Monday Jan 30 2pmET/ 7pmGMT/ 8pmCEST

4/#MondayNightIBD #UEGWeek
🆓 #CME🔗bit.ly/3XgqsH8

👇#IBDPoll 1️⃣
🟢In the True North open-label extension, the findings indicated that approx 1/2 the pts who failed to achieve a CR after 10wks of ozanimod induction tx benefitted from which of the following:

5/#MondayNightIBD #UEGWeek
#CME🔗bit.ly/3XgqsH8
📲Tweet your❓for Mon LIVE Q&A

👇#IBDPoll 2⃣
🟢Which drug combo were given in the Ph2a VEGA study to show the potential of dual inhibition of IL-23 & TNFα to more effectively induce CR & remission in pts w mod-sev UC?

6/#MondayNightIBD #UEGWeek
📲Tweet your❓for Mon LIVE Q&A @ 2p ET/ 7p GMT/ 8p CEST

👇#IBDPoll 3⃣
🟢Which of the following PRO questionnaires assesses pt fatigue using a 13-item tool & 5-point scale, where a ⬆️higher score indicates a better pt outcome?

7/#MondayNightIBD #UEGWeek
#CME🔗bit.ly/3XgqsH8

👇#IBDPoll 4⃣
🟢The U-ACHIEVE Maintenance study, looked @ pts w UC who responded to induction tx w upadacitinib @ 8wks

Which tx group led to greater clinical remission per adapted Mayo score at wk 52 compared to PBO?

8/#MondayNightIBD #UEGWeek @my_ueg @BonumCe

🚨Don’t forget the Live Q+A🚨
🗓️Mon. Jan 30
⏰14:00 (2p) EST / 19:00 GMT / 20:00 CEST

📺 Join experts @CharlieMuz @Iris_Dotan @MRegueiroMD & @DCharabaty

🙋‍♀️🙋🏽🙋🏻🙋🏾‍♀️🙋🙋‍♀️🙋🏽🙋🏻🙋🏾‍♀️🙋🙋‍♀️🙋🏽🙋🏻🙋🏾‍♀️🙋

📲✍️ Tweet your ❓ to be discussed on Mon👇